Status: Recruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
Participants needed: 270
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Ambros Therapeutics, Inc.Updated: Jul 1, 2026Locations: 15
Eligibility criteria
Male or female participant ≥ 18 years of age at time of Screening. [+11]
A current or prior diagnosis of CRPS Type 2 or CRPS not otherwise specified (CRP... [+17]